Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Blenrep
Pharma
With GSK's 2nd Blenrep win, analysts see blockbuster comeback
Blenrep isn't included in GSK's £38 billion sales outlook for 2031, but two groups of analysts are projecting blockbuster-level sales for the drug.
Angus Liu
Mar 7, 2024 10:14am
GSK details combo data that could bring Blenrep back to life
Feb 5, 2024 5:00pm
After pulling Blenrep, GSK touts combo trial in multiple myeloma
Nov 27, 2023 10:36am
JPM: GSK's Miels talks RSV and mRNA vaccines, oncology setbacks
Jan 11, 2023 5:45pm
FDA's Califf weighs in on GSK's fast accelerated approval pull
Jan 11, 2023 10:36am
GSK pulls Blenrep accelerated approval days after trial flop
Nov 22, 2022 11:30am